Teleflex Incorporated TFX
155.30 USD +0.57 (+0.37%)
At closeNov 10, 2026, 5:36 PM EST
155.30 0.00 0.00%
After hours · Nov 10, 5:36 PM ET
152.56 Day range 156.43
100.18 52-week range 156.67
- YTD
- +27.25%
- 1 year
- +43.84%
News
benzinga.com Truist Securities Maintains Hold on Teleflex, Raises Price Target to $167 Truist Securities analyst Ravi Misra maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $142 to $167.
marketbeat.com Teleflex Q3 Earnings Call Highlights Teleflex NYSE: TFX raised its 2026 adjusted earnings outlook after reporting higher third-quarter earnings and a return to growth in its Interventional business, although the company said a planned…
benzinga.com RBC Capital Maintains Outperform on Teleflex, Raises Price Target to $175 RBC Capital analyst Kendall Au maintains Teleflex (NYSE:TFX) with a Outperform and raises the price target from $155 to $175.- benzinga.com Wells Fargo Maintains Equal-Weight on Teleflex, Raises Price Target to $167 Wells Fargo analyst Larry Biegelsen maintains Teleflex (NYSE:TFX) with a Equal-Weight and raises the price target from $138 to $167.
seekingalpha.com Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript
zacks.com Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
zacks.com Teleflex (TFX) Q3 Earnings Surpass Estimates Teleflex (TFX) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $3.67 per share a year ago.
benzinga.com Teleflex Q3 2026 Earnings Call Transcript Teleflex (NYSE:TFX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
businesswire.com Teleflex Announces Quarterly Dividend WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.…
benzinga.com Teleflex Raises FY2026 Adj EPS Guidance from $6.90-$7.20 to $7.50-$7.75 vs $7.22 Est; Lowers FY2026 Sales Guidance from $2.260B-$2.280B to $2.256B-$2.276B vs $2.269B Est Teleflex (NYSE:TFX) raises FY2026 Adj EPS guidance from $6.90-$7.20 to $7.50-$7.75 vs $7.22 analyst estimate. Lowers FY2026 sales outlook from $2.260 billion-$2.280 billion to $2.256 billion-$2.276…
benzinga.com Teleflex Q3 Adj. EPS $2.63 Beats $1.90 Estimate, Sales $567.800M Beat $566.772M Estimate Teleflex (NYSE:TFX) reported quarterly earnings of $2.63 per share which beat the analyst consensus estimate of $1.90 by 38.42 percent. The company reported quarterly sales of $567.800 million which…
businesswire.com Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 30, 2026. Third quarter 2026 continuing…
benzinga.com Teleflex Receives FDA Breakthrough Device Designation For Its Freesolve Resorbable Magnesium Scaffold For Percutaneous Coronary Intervention To qualify for a BDD, device technology must address an unmet clinical need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly…
benzinga.com Truist Securities Maintains Hold on Teleflex, Lowers Price Target to $142 Truist Securities analyst Richard Newitter maintains Teleflex (NYSE:TFX) with a Hold and lowers the price target from $150 to $142.
benzinga.com Teleflex Completes Patient Enrollment In BIOMAG-LL Clinical Study, Evaluating Freesolve RMS In 35 mm And 40 mm Lengths For Treatment Of De Novo Coronary Lesions Up To 38 mm 102 patients enrolled across 14 European centers to assess safety and clinical performance of 35 mm and 40 mm Freesolve™ Resorbable Magnesium Scaffolds in long coronary lesionsTeleflex Incorporated…
benzinga.com Full Transcript: Teleflex Q2 2026 Earnings Call Teleflex (NYSE:TFX) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by…
benzinga.com This Nice Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday Wall Street analysts upgraded Grocery Outlet, NICE and Pinnacle Financial Partners; targets are $15, $150 and $118, respectively.
benzinga.com This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target changes.
benzinga.com Nasdaq 100 Sinks, Oil Rallies as Trump Rejects Iran's Hormuz Plan: Stock Market Today Stocks slipped at midday Monday as oil surged and yields hit a 19-year high after Trump rejected Iran's Hormuz plan; MongoDB tumbled 18%.
benzinga.com This First Solar Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday Analysts upgraded Royal Caribbean, Park Hotels, First Solar, Teleflex and CF Industries, with several receiving higher price targets.- benzinga.com B of A Securities Upgrades Teleflex to Buy, Raises Price Target to $158 B of A Securities analyst Craig Bijou upgrades Teleflex (NYSE:TFX) from Neutral to Buy and raises the price target from $145 to $158.
benzinga.com Nvidia To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For Tuesday Top Wall Street analysts upgraded and raised price targets for FLNC, DT, NVDA, SNOW, TFX, COIN, and EXPE. See how other analysts view these stocks.- benzinga.com Needham Maintains Buy on Teleflex, Raises Price Target to $170 Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target from $159 to $170.
- benzinga.com UBS Maintains Neutral on Teleflex, Raises Price Target to $158 UBS analyst Patrick Wood maintains Teleflex (NYSE:TFX) with a Neutral and raises the price target from $145 to $158.
benzinga.com Truist Securities Maintains Hold on Teleflex, Raises Price Target to $150 Truist Securities analyst Ravi Misra maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $143 to $150.
benzinga.com Piper Sandler Reiterates Overweight on Teleflex, Raises Price Target to $169 Piper Sandler analyst Jason Bednar reiterates Teleflex (NYSE:TFX) with a Overweight and raises the price target from $160 to $169.- benzinga.com Teleflex Raises FY2026 Adj EPS Guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 Est; Lowers FY2026 Sales Guidance from $2.280B-$2.300B to $2.260B-$2.280B vs $2.287B Est Teleflex (NYSE:TFX) raises FY2026 Adj EPS guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 analyst estimate. Lowers FY2026 sales outlook from $2.280 billion-$2.300 billion to $2.260 billion-$2.280…
- benzinga.com Teleflex Q2 Adj. EPS $1.76 Beats $1.28 Estimate, Sales $570.332M Beat $559.596M Estimate Teleflex (NYSE:TFX) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.28 by 37.5 percent. This is a 52.82 percent decrease over earnings of $3.73 per…
- benzinga.com Needham Maintains Buy on Teleflex, Raises Price Target to $159 Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target from $147 to $159.
- benzinga.com UBS Initiates Coverage On Teleflex with Neutral Rating, Announces Price Target of $145 UBS analyst Patrick Wood initiates coverage on Teleflex (NYSE:TFX) with a Neutral rating and announces Price Target of $145.
- benzinga.com Teleflex Awarded National Premier Contract for Central Venous, Arterial and Intraosseous Access Devices Teleflex Incorporated (NYSE:TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier…
benzinga.com Mizuho Maintains Neutral on Teleflex, Raises Price Target to $145 Mizuho analyst Anthony Petrone maintains Teleflex (NYSE:TFX) with a Neutral and raises the price target from $140 to $145.- benzinga.com BMO Capital Initiates Coverage On Teleflex with Outperform Rating, Announces Price Target of $159 BMO Capital analyst Vik Chopra initiates coverage on Teleflex (NYSE:TFX) with a Outperform rating and announces Price Target of $159.
- benzinga.com Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold Dr. Itsik Ben-Dor, MedStar Health in Washington, D.C., is the first implanter in the United States (U.S.) in the IDE trial of Freesolve™ RMS. Designed as a pivotal trial to support future regulatory…
- benzinga.com Teleflex Presents 4‑Yr Follow‑Up Data From First-in-Human BIOMAG-I Clinical Study At EuroPCR Conference Persistently Low Target Lesion Failure and No New Cardiac-Related EventTeleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up…
- benzinga.com Piper Sandler Upgrades Teleflex to Overweight, Raises Price Target to $160 Piper Sandler analyst Matt O'Brien upgrades Teleflex (NYSE:TFX) from Neutral to Overweight and raises the price target from $140 to $160.
- benzinga.com Teleflex Commences $500M Senior Notes Due 2032 Offering Teleflex Incorporated (NYSE: TFX) ("Teleflex") announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2032 (the "Notes"), subject to…
- benzinga.com Teleflex Says Interventional Urology Business Unit Releases New Clinical Data Across Two Major Urological Congresses, Reinforcing Value Of UroLift System And Barrigel Rectal Spacer In Improving Patient-Centered Outcomes First Head-to-Head Randomized Control Study (RCT) Reinforces Early Patient Experience Benefits and 12-month Durability of the UroLift™ System versus Rezūm™Three-Year Data Demonstrate Sustained…
- benzinga.com Truist Securities Reiterates Hold on Teleflex, Raises Price Target to $143 Truist Securities analyst Ravi Misra reiterates Teleflex (NYSE:TFX) with a Hold and raises the price target from $135 to $143.
- benzinga.com RBC Capital Upgrades Teleflex to Outperform, Raises Price Target to $155 RBC Capital analyst Shagun Singh upgrades Teleflex (NYSE:TFX) from Sector Perform to Outperform and raises the price target from $135 to $155.
- benzinga.com Wells Fargo Maintains Equal-Weight on Teleflex, Raises Price Target to $138 Wells Fargo analyst Larry Biegelsen maintains Teleflex (NYSE:TFX) with a Equal-Weight and raises the price target from $130 to $138.
- benzinga.com Teleflex Affirms FY2026 Adj EPS Guidance of $6.25-$6.55 vs $6.72 Est Teleflex (NYSE:TFX) affirms FY2026 Adj EPS guidance from $6.25-$6.55 to $6.25-$6.55 vs $6.72 analyst estimate. Affirms FY2026 sales outlook from $2.280 billion-$2.300 billion to $2.280 billion-$2.300…
- benzinga.com Teleflex Q1 Adj. EPS $1.39 Beats $1.21 Estimate, Sales $548.300M Beat $533.339M Estimate Teleflex (NYSE:TFX) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.21 by 14.88 percent. This is a 52.23 percent decrease over earnings of $2.91 per…
benzinga.com Nasdaq 100 Tops Records As Iran Ceasefire Extends, GE Vernova Soars 13%: Stock Market Today Tech stocks brushed new record highs during midday Wednesday, as a fresh wave of blockbuster corporate earnings propelled mega-cap technology and speculative names higher.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Teleflex Stock Surges Over 8% In Pre-Market Trading: Here's Why Teleflex rose 12.17% in pre-market trading after a joint private equity bid, with the offer still under review and no deal certain.- benzinga.com 'CVC, GTCR Weigh Take-Private Of Medical Equipment Provider Teleflex' - Bloomberg https://www.bloomberg.com/news/articles/2026-04-21/cvc-gtcr-weigh-take-private-of-medical-equipment-provider-teleflex
- benzinga.com Raymond James Upgrades Teleflex to Outperform, Announces $128 Price Target Raymond James analyst Jayson Bedford upgrades Teleflex (NYSE:TFX) from Market Perform to Outperform and announces $128 price target.
benzinga.com Activist Investor Urges Teleflex To Engage Potential Buyers Teleflex rises 5.37% as Irenic pushes for sale talks; weak momentum, mixed signals, and cautious analyst targets shape outlook.- benzinga.com Teleflex Says Previously Announced Sale Transactions On Track To Close In H2 of 2026; Expects $1.8B of Net Proceeds For Buyback And Debt Paydown; Restructuring Plan Expected To Achieve $50M Annual Pre-Tax Cost Savings By Mid-2028 Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today issued the following statement in response to the press release issued by Irenic Capital Management L.P.…